Literature DB >> 21430658

Opportunities for use of human iPS cells in predictive toxicology.

B D Anson1, K L Kolaja, T J Kamp.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21430658      PMCID： PMC3593635          DOI： 10.1038/clpt.2011.9

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  29 in total

1.  The use of hepatocytes to investigate drug toxicity.

Authors:  María José Gómez-Lechón; José V Castell; María Teresa Donato
Journal:  Methods Mol Biol       Date:  2010

2.  Validation of the embryonic stem cell test in the international ECVAM validation study on three in vitro embryotoxicity tests.

Authors:  Elke Genschow; Horst Spielmann; Gabriele Scholz; Ingeborg Pohl; Andrea Seiler; Nicole Clemann; Susanne Bremer; Klaus Becker
Journal:  Altern Lab Anim       Date:  2004-09       Impact factor: 1.303

Review 3.  Mechanisms of drug-induced liver disease.

Authors:  Basuki K Gunawan; Neil Kaplowitz
Journal:  Clin Liver Dis       Date:  2007-08       Impact factor: 6.126

Review 4.  New technologies and screening strategies for hepatotoxicity: use of in vitro models.

Authors:  Donna M Dambach; Barbara A Andrews; Frederic Moulin
Journal:  Toxicol Pathol       Date:  2005       Impact factor: 1.902

Review 5.  Cardiac troponins--biochemical markers of cardiac toxicity after cytostatic therapy.

Authors:  D Urbanová; L Urban; A Carter; D Maasova; B Mladosievicova
Journal:  Neoplasma       Date:  2006       Impact factor: 2.575

6.  Alfuzosin delays cardiac repolarization by a novel mechanism.

Authors:  Antonio E Lacerda; Yuri A Kuryshev; Yuan Chen; Muthukrishnan Renganathan; Heather Eng; Sanjay J Danthi; James W Kramer; Tianen Yang; Arthur M Brown
Journal:  J Pharmacol Exp Ther       Date:  2007-11-06       Impact factor: 4.030

Review 7.  Anthracycline-induced cardiotoxicity.

Authors:  A L A Ferreira; L S Matsubara; B B Matsubara
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2008-10

8.  Derivation of induced pluripotent stem cells from human peripheral blood T lymphocytes.

Authors:  Matthew E Brown; Elizabeth Rondon; Deepika Rajesh; Amanda Mack; Rachel Lewis; Xuezhu Feng; Laura Jo Zitur; Randall D Learish; Emile F Nuwaysir
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

9.  Induced pluripotent stem cells from a spinal muscular atrophy patient.

Authors:  Allison D Ebert; Junying Yu; Ferrill F Rose; Virginia B Mattis; Christian L Lorson; James A Thomson; Clive N Svendsen
Journal:  Nature       Date:  2008-12-21       Impact factor: 49.962

10.  Predicting human developmental toxicity of pharmaceuticals using human embryonic stem cells and metabolomics.

Authors:  Paul R West; April M Weir; Alan M Smith; Elizabeth L R Donley; Gabriela G Cezar
Journal:  Toxicol Appl Pharmacol       Date:  2010-05-21       Impact factor: 4.219
View more
  61 in total

Review 1.  Cellular reprogramming: a new technology frontier in pharmaceutical research.

Authors:  Amy Brock; Hui-Tong Goh; Binxia Yang; Yu Lu; Hu Li; Yuin-Han Loh
Journal:  Pharm Res       Date:  2011-11-09       Impact factor: 4.200

2.  High-content assays for hepatotoxicity using induced pluripotent stem cell-derived cells.

Authors:  Oksana Sirenko; Jayne Hesley; Ivan Rusyn; Evan F Cromwell
Journal:  Assay Drug Dev Technol       Date:  2013-11-14       Impact factor: 1.738

3.  High-content high-throughput assays for characterizing the viability and morphology of human iPSC-derived neuronal cultures.

Authors:  Oksana Sirenko; Jayne Hesley; Ivan Rusyn; Evan F Cromwell
Journal:  Assay Drug Dev Technol       Date:  2014 Nov-Dec       Impact factor: 1.738

Review 4.  Electrical and Mechanical Strategies to Enable Cardiac Repair and Regeneration.

Authors:  Hung Cao; Bong Jin Kang; Chia-An Lee; K Kirk Shung; Tzung K Hsiai
Journal:  IEEE Rev Biomed Eng       Date:  2015-05-11

Review 5.  Genetics of congenital and drug-induced long QT syndromes: current evidence and future research perspectives.

Authors:  Saagar Mahida; Andrew J Hogarth; Campbell Cowan; Muzahir H Tayebjee; Lee N Graham; Christopher B Pepper
Journal:  J Interv Card Electrophysiol       Date:  2013-03-21       Impact factor: 1.900

6.  Micropatterning Facilitates the Long-Term Growth and Analysis of iPSC-Derived Individual Human Neurons and Neuronal Networks.

Authors:  Lena F Burbulla; Kristin G Beaumont; Milan Mrksich; Dimitri Krainc
Journal:  Adv Healthc Mater       Date:  2016-04-24       Impact factor: 9.933

7.  Assessment of beating parameters in human induced pluripotent stem cells enables quantitative in vitro screening for cardiotoxicity.

Authors:  Oksana Sirenko; Evan F Cromwell; Carole Crittenden; Jessica A Wignall; Fred A Wright; Ivan Rusyn
Journal:  Toxicol Appl Pharmacol       Date:  2013-10-01       Impact factor: 4.219

8.  High-Content Assay Multiplexing for Muscle Toxicity Screening in Human-Induced Pluripotent Stem Cell-Derived Skeletal Myoblasts.

Authors:  William D Klaren; Ivan Rusyn
Journal:  Assay Drug Dev Technol       Date:  2018-08-02       Impact factor: 1.738

9.  Prediction of developmental chemical toxicity based on gene networks of human embryonic stem cells.

Authors:  Junko Yamane; Sachiyo Aburatani; Satoshi Imanishi; Hiromi Akanuma; Reiko Nagano; Tsuyoshi Kato; Hideko Sone; Seiichiroh Ohsako; Wataru Fujibuchi
Journal:  Nucleic Acids Res       Date:  2016-05-20       Impact factor: 16.971

10.  Extracellular Matrix-Mediated Maturation of Human Pluripotent Stem Cell-Derived Cardiac Monolayer Structure and Electrophysiological Function.

Authors:  Todd J Herron; Andre Monteiro Da Rocha; Katherine F Campbell; Daniela Ponce-Balbuena; B Cicero Willis; Guadalupe Guerrero-Serna; Qinghua Liu; Matt Klos; Hassan Musa; Manuel Zarzoso; Alexandra Bizy; Jamie Furness; Justus Anumonwo; Sergey Mironov; José Jalife
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.